We are live on ! Find out more
LPCN icon

Lipocine
LPCN

30 hedge funds and large institutions have $8.88M invested in Lipocine in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more capital invested

Capital invested by funds: $5.56M → $8.88M (+$3.32M)

0.07% more ownership

Funds ownership: 0.68% → 0.75% (+0.07%)

6% less funds holding

Funds holding: 32 → 30 (-2)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

93% less call options, than puts

Call options by funds: $5K | Put options by funds: $76K

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
8
Closed
6
Calls
$5K
Puts
$76K
Net Calls
-$71K
Net Calls Change
-$52K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$366K
2
Renaissance Technologies
Renaissance Technologies
New York
+$267K
3
CL
Choreo LLC
Illinois
+$154K
4
Millennium Management
Millennium Management
New York
+$56.3K
5
QCMA
Quad Capital Management Advisors
New York
+$47.2K

Top Sellers

1
Mercer Global Advisors
Mercer Global Advisors
Colorado
-$94.5K
2
PAM
Panagora Asset Management
Massachusetts
-$43K
3
Deutsche Bank
Deutsche Bank
Germany
-$34K
4
SIM
Spark Investment Management
New York
-$34K
5
Group One Trading
Group One Trading
Illinois
-$22.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2M +$366K +9,115 +28%
Renaissance Technologies
2
Renaissance Technologies
New York
$1.71M +$267K +6,654 +23%
Ameriprise
3
Ameriprise
Minnesota
$1.66M +$46.6K +1,162 +3%
BlackRock
4
BlackRock
New York
$1.05M +$20.9K +521 +2%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$551K – – –
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$404K – – –
Mercer Global Advisors
7
Mercer Global Advisors
Colorado
$365K -$94.5K -2,353 -24%
CL
8
Choreo LLC
Illinois
$183K +$154K +3,836 New
Northern Trust
9
Northern Trust
Illinois
$141K -$1.89K -47 -2%
KCM
10
Knoll Capital Management
Florida
$141K – – –
California Public Employees Retirement System
11
California Public Employees Retirement System
California
$129K – – –
QCMA
12
Quad Capital Management Advisors
New York
$124K +$47.2K +1,176 +83%
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$111K +$40.9K +1,019 +78%
FIA
14
FNY Investment Advisers
New York
$74K +$29.3K +729 +87%
Millennium Management
15
Millennium Management
New York
$67K +$56.3K +1,403 New
Bank of New York Mellon
16
Bank of New York Mellon
New York
$39K – – –
CG
17
Cutler Group
California
$36K – – –
State Street
18
State Street
Massachusetts
$35K – – –
LTFS
19
Ladenburg Thalmann Financial Services
Florida
$19K – – –
Group One Trading
20
Group One Trading
Illinois
$13K -$22.5K -560 -67%
JP Morgan Chase
21
JP Morgan Chase
New York
$8K – – –
Bank of America
22
Bank of America
North Carolina
$4K -$12.8K -320 -81%
Morgan Stanley
23
Morgan Stanley
New York
$4K -$562 -14 -14%
BFEC
24
Benjamin F. Edwards & Company
Missouri
$4K – – –
UBS Group
25
UBS Group
Switzerland
$3K -$8.31K -207 -78%
1
2

LPCN Hedge Fund Activity: Q3 2019 in Review

30 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q3 2019, worth a combined $8.88M — up 60% from $5.56M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of LPCN and 4 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 7 added.

The largest buyer was Vanguard Group, adding an estimated $366K. The largest seller was Mercer Global Advisors, cutting an estimated $94.5K.

  • 30 institutional investors held Lipocine (LPCN) as of Q3 2019, down from 32 in Q2 2019.
  • Funds reported $8.88M of Lipocine stock for Q3 2019, up 60% quarter-over-quarter.
  • 4 funds opened new Lipocine positions in Q3 2019 and 6 closed out, a net change of -2 holders.
  • The largest Lipocine buyer in Q3 2019 was Vanguard Group, an estimated $366K added.
  • The largest Lipocine seller in Q3 2019 was Mercer Global Advisors, an estimated $94.5K sold.

Based on aggregated 13F filings for Q3 2019.